Apoptotic regulation of monocytes/macrophages appears to be closely associated with chronic inflammatory reactions. Since it was demonstrated earlier that certain bacterial cell components are involved in apoptotic regulation of these cells, in the present study, we investigated whether the bacterial fimbria, an important cell structure involved in bacterial adherence to host cells, regulates apoptosis of human monocytic THP-1 cells induced under growth factor deprivation. To investigate this point, we used fimbriae of Porphyromonas gingivalis, a pathogen causing periodontal disease, which is a chronic inflammatory disease. The fimbriae inhibited apoptosis of the cells under growth factor deprivation. This inhibitory action of the fimbriae was completely neutralized by anti-fimbrial antibody. The fimbriae stimulated activation of extracellular signalregulated kinase (ERK) and expression of cyclin-dependent kinase inhibitor p21 Cip/WAF1 (p21) in the cells. The stimulatory effect of the fimbriae on the expression of the p21 protein was inhibited by treatment with PD98059, a specific inhibitor of ERK. The cell apoptosis was inhibited by treatment with Ac-DEVD-CHO, an inhibitor of caspase-3. The fimbriae inhibited the serum withdrawal-induced cleavage of the caspase-3 proform and poly(ADP-ribose) polymerase, one of the caspase-3 substrates. Furthermore, PD98059 and antisense p21 oligonucleotide blocked the fimbrial inhibition of apoptosis and caspase-3 activation of the cells induced by serum withdrawal. These results show that the bacterial fimbriae inhibited apoptosis of THP-1 cells induced under growth factor deprivation via ERK-dependent expression of p21. The present study suggests that bacterial fimbriae act as potent regulators of chronic inflammatory disease, e.g., periodontal disease, through blocking apoptosis of monocytes/macrophages.
It has been well documented that apoptosis plays an important role in the inflammatory response, tumorigenesis, and embryonic development (4) . Apoptosis is characterized by distinctive morphological and biochemical changes involving nuclear and chromatin condensation, cell membrane blebbing, and endonuclease activity resulting in DNA fragmentation (37) . Therefore, much interest has been generated in demonstrating the signaling mechanisms of specific genes that regulate apoptosis.
Recent studies (30, 32, 48) have shown that several pathogenic bacteria function as promoters or inhibitors of apoptosis of monocytes/macrophages. These observations suggest that several cell components of these bacteria are involved in an important pathogenic mechanism promoting inflammation and concomitant disease via apoptosis of monocytes/macrophages. In fact, lipopolysaccharide of gram-negative bacteria is able to regulate the apoptosis of neutrophils and monocytes/macrophages via direct or indirect action through endogenous cytokines (1, 10, 13, 20, 26-28, 32, 35, 44) .
Porphyromonas gingivalis is a pathogen causing periodontal disease, a typical chronic inflammatory disease (14, 23, 24, 41, 47) . The bacterial fimbria is an important cell structure that contributes to the adherence to and invasion of host cells. Also, several studies (11, 16-19, 31, 40) have shown that the fimbriae function as a virulence factor in inflammatory reactions because they stimulate production of inflammatory cytokines by macrophages and fibroblasts. These observations suggest the involvement of the fimbriae as regulators of inflammatory reactions caused by bacterial infection. Since apoptosis is an important biological phenomenon regulating the number of monocytes/macrophages at sites of inflammation, it was of interest for us to investigate whether bacterial fimbriae play functional roles as regulators of monocytic-cell apoptosis and to explore a possible intracellular signaling pathway regulating the action of the fimbriae on cell apoptosis.
For this purpose, we investigated the regulatory role of the fimbriae of P. gingivalis in serum withdrawal-induced apoptosis of human monocytic THP-1 cells. We show in this study that P. gingivalis fimbriae inhibited serum withdrawal-induced apoptosis of THP-1 cells and that they did so via extracellular signalregulated kinase (ERK)-and mitogen-activated protein kinase (MAPK)-dependent expression of p21 Cip/WAF1 (p21), a cyclin-dependent kinase inhibitor.
L-aspart-1-al), a caspase-1 family inhibitor, and Ac-DEVD-CHO (acetyl-L-aspartyl-L-glutamyl-L-valyl-L-aspart-1-al), a caspase-3 family inhibitor, were purchased from Peptide Institute, Inc. (Osaka, Japan).
Antisense oligonucleotide. The antisense oligonucleotide used was based on the p21 coding sequence. Antisense p21 oligonucleotide (5Ј-TCC CCA GCC GGT TCT GAC AT-3Ј) is complementary to the region around the initiation codon, and the control sense p21 oligonucleotide (5Ј-ATG TCA GAA CCG GCT GGG GA-3Ј) is complementary to the antisense p21 oligonucleotide. Each oligonucleotide and Lipofectin (Life Technologies, Inc., Rockville, Md.) were incubated for 15 min at 37°C. The mixture was diluted with medium to a final concentration of 0.5 or 1 M oligonucleotide and added to the THP-1 cells.
RESULTS
P. gingivalis fimbriae inhibit THP-1 cell apoptosis under growth factor deprivation. In the absence of an appropriate survival stimulus, human monocytes undergo spontaneous apoptosis (13, (26) (27) (28) . Therefore, we first looked by DNA fragmentation assay for apoptosis of the untreated or fimbriatreated cells under growth factor deprivation. In preliminary experiments, we observed that the fimbriae inhibited the apoptosis of THP-1 cells under these conditions in a dose-dependent manner (1 to 5 g of protein/ml), with the maximum inhibitory action at 5 g of protein/ml of fimbriae. Therefore, we used this fimbrial concentration in the following experiments. Figure 1A shows that the characteristic DNA laddering of the cells under these conditions increases in a culture timerelated manner. However, such significantly increased DNA laddering was not observed when the medium was supplemented with 5% serum. Interestingly, we observed that the fimbriae clearly inhibit DNA laddering of the cells induced under growth factor deprivation. In addition, this inhibitory action of the fimbriae was also supported by the results of the diphenylamine assay (Fig. 1B) . Furthermore, to confirm the inhibitory action of the fimbriae, we examined by DNA fragmentation and diphenylamine assays whether the fimbrial inhibition could be neutralized by a monoclonal antibody against the fimbriae. The monoclonal antibody completely neutralized the fimbrial inhibition of cell apoptosis ( Fig. 1C and D) .
P. gingivalis fimbriae stimulate expression of p21 in THP-1 cells. Many studies (2, 3, 15, 34, 42, 43) have shown that expression of p21 is essential for the differentiation and survival of several kinds of cells. Also, there is a study showing that the fimbriae were able to induce monocytic-cell differentiation (21) . Therefore, we suspected the involvement of p21 expression in the fimbrial inhibition of THP-1 cell apoptosis under growth factor deprivation. Based on this suspicion, we examined by Western blot analysis whether the fimbriae could stimulate the expression of p21 protein in the cells under these culture conditions. As a result, we observed the clearly stimulated expression of p21 protein in the cells when the expression was examined at 12 or 24 h after the initiation of the fimbrial treatment (data not shown). In addition, using an antisense p21 oligonucleotide, we confirmed the fimbria-stimulated expression of the p21 protein. Figure 2 shows that the fimbriastimulated expression of the p21 protein was inhibited by antisense p21 oligonucleotide treatment but not by sense p21 oligonucleotide. These results clearly demonstrate that the fimbriae act as potent stimulators of p21 expression in the cells in the absence of growth factors.
On the other hand, since Bcl-2, an oncoprotein, acts as an inhibitor of cell apoptosis, we also examined by Western blot analysis the effect of the fimbriae on the expression of the Bcl-2 protein in THP-1 cells under growth factor deprivation. Figure  3 shows that the fimbriae had no effect on the expression of the Bcl-2 protein, suggesting to us that the regulation of Bcl-2 expression is probably not involved in the fimbrial inhibition of THP-1 cell apoptosis induced under growth factor deprivation. P. gingivalis fimbriae inhibit THP-1 cell apoptosis via p21 under growth factor deprivation. The fimbrial stimulation of the expression of the p21 protein in THP-1 cells suggested to us the possibility that the p21 protein is involved in the fimbrial inhibition of cell apoptosis under growth factor deprivation. To demonstrate the possibility, we examined whether fimbrial inhibition is blocked by antisense p21 oligonucleotide treatment, and we observed that the antisense oligonucleotide at 1 M, but not the sense oligonucleotide, significantly blocked fimbrial inhibition of apoptosis (Fig. 4) . These results indicate an important role for the p21 protein in the inhibitory action of the fimbriae on cell apoptosis under growth factor deprivation.
P. gingivalis fimbriae inhibit THP-1 cell apoptosis under growth factor deprivation via ERK-and MAPK-dependent expression of p21. Since we found the p21 protein to be involved in the fimbrial inhibition of THP-1 cell apoptosis under growth factor deprivation, it was of interest to us to explore which protein kinase acts in signaling of the fimbria-stimulated expression of p21 in the cells. Interestingly, several studies (5, 25) have suggested that p21 expression is induced by activation FIG. 1. Inhibitory effect of P. gingivalis fimbriae on THP-1 cell apoptosis induced by growth factor deprivation. (A) THP-1 cells were incubated with or without serum in the absence or presence of fimbriae at 5 g of protein/ml. DNA fragments from the supernatant of the lysed cells were isolated at selected times after the initiation of the cultures and then subjected to agarose gel electrophoresis. X174 RF DNA HaeIII fragments were used as molecular weight markers (M). (B) The cells were treated as described for panel A, and DNA fragmentation was quantified by the diphenylamine assay. (C) Cells in serum-free medium were incubated in the absence or presence of fimbriae at 5 g of protein/ml that had been pretreated or not with anti-fimbrial antibody (Ab). DNA fragments from the supernatant of the lysed cells were analyzed by agarose gel electrophoresis at 24 h after the initiation of the cultures. (D) Cells were treated as described for panel C, and DNA fragmentation was quantified by the diphenylamine assay at 24 h after the initiation of the cultures. The results of the diphenylamine assays are expressed as the mean Ϯ standard deviation of three cultures. An identical experiment independently performed gave similar results. of ERK and MAPK. Therefore, using Western blot analysis with anti-phosphorylated p44/42 MAPK antibody, we investigated whether the fimbriae stimulated expression of p21 in THP-1 cells through activation (i.e., phosphorylation) of ERK and MAPK. As shown in Fig. 5 , although they had no effect on the total amount of the ERK and MAPK proteins in THP-1 cells, the fimbriae markedly increased the expression of the phosphorylated forms of ERK and MAPK in the cells. Since a recent study (2) demonstrated that p21 inhibits apoptosis of monocytic cells via inhibition of c-Jun N-terminal kinasestress-activated protein kinase (JNK-SAPK) activation, we also examined whether JNK-SAPK activation was involved in THP-1 cell apoptosis under growth factor deprivation. Although the data are not shown, the increased expression of phosphorylated JNK-SAPK was not observed in the absence of growth factors. In addition, our Western blot analysis showed that the fimbria-stimulated expression of p21 protein in the cells was inhibited by PD98059, a specific inhibitor of mitogenactivated protein-ERK kinase (MEK) activation (12) (Fig.   6A ). These observations caused to us to investigate the effect of PD98059 on the fimbrial inhibition of cell apoptosis. Figure  6B shows that the inhibitor blocked the fimbrial inhibition of cell apoptosis in a dose-dependent manner. Taken together, these results suggest that the fimbriae inhibited THP-1 cell apoptosis under growth factor deprivation via ERK-and MAPK-dependent expression of p21.
Caspase-3 inhibitor blocks growth factor deprivation-induced apoptosis of THP-1 cells. It is well demonstrated that the caspase cascade plays an important role in the signaling of apoptosis of many kinds of cells. Therefore, using Ac-YVAD-CHO and Ac-DEVD-CHO, inhibitors of caspase-1 and -3, respectively, we examined which caspase mediates THP-1 cell apoptosis under growth factor deprivation. As shown in Fig. 7 , cell apoptosis was significantly inhibited by the caspase-3 inhibitor but not by the caspase-1 inhibitor, thus suggesting that caspase-3 activation may be involved in cell apoptosis.
P. gingivalis fimbriae inhibit growth factor deprivation-induced caspase-3 activation in THP-1 cells via activation of ERK and MAPK and expression of p21. To confirm caspase-3 activation during induction of THP-1 cell apoptosis under growth factor deprivation, we examined by Western blot analysis whether the caspase-3 proform and PARP would be cleaved in the cells under growth factor deprivation. As shown in Fig. 8A , the caspase-3 proform and PARP of the cells in the presence of serum were cleaved when the cells were incubated under growth factor deprivation. However, the fimbriae inhibited the cleavage of the caspase-3 proform and PARP in the cells. Importantly, our interest was to explore whether the fimbrial inhibition of caspase-3 activation would be blocked by antisense p21 oligonucleotide and PD98059 treatment. We observed that the fimbrial inhibition of caspase-3 activation in the cells was blocked by antisense p21 oligonucleotide and PD98059 treatment, because the inhibition of cleavage of the caspase-3 proform and PARP in fimbria-treated cells was reduced by the treatment (Fig. 8B and C) . bacteria. Therefore, using fimbriae of P. gingivalis, which is a pathogen causing periodontal disease, we investigated the regulatory role of bacterial fimbriae in the apoptosis of cultured human monocytic THP-1 cells. The present study demonstrates that the bacterial fimbriae inhibited THP-1 cell apoptosis under growth factor deprivation via ERK-and MAPKdependent expression of p21. Growth factor deprivation has been shown to provoke apoptosis in a variety of cells, including monocytes/macrophages and endothelial cells (8, 9, 13, (26) (27) (28) . Although the induction of monocytic apoptosis under growth factor or serum withdrawal conditions is physiologically irrelevant, these experimental conditions appear to provide an effective method for examining the regulation of monocytic apoptosis. Therefore, in this study, we employed this experimental design to explore the regulation of apoptosis in THP-1 cells by P. gingivalis fimbriae. In fact, we observed that THP-1 cells effectively undergo apoptosis upon growth factor deprivation as determined by detection of the characteristic genomic DNA laddering. The bacterial fimbriae inhibited monocytic-cell apoptosis. This inhibitory action of fimbriae was confirmed by their inability to rescue the apoptotic cells when the fimbriae were pretreated with a specific monoclonal antibody against themselves. To our knowledge, this is the first demonstration that bacterial fimbriae play a functional role as inhibitors of monocytic-cell apoptosis.
It is known that p21 is involved in DNA damage repair, differentiation, and apoptosis, and many studies (2, 3, 15, 34, 42, 43) have demonstrated that expression of p21 inhibits apoptosis of several kinds of cells, such as monocytic cells, muscle cells, neuroblastoma cells, and melanoma cells. Therefore, we explored whether p21 was involved in the fimbrial inhibition of THP-1 cell apoptosis induced under growth factor deprivation. Using Western blot analysis, we observed that expression of p21 protein in the cells markedly increased following the fimbrial treatment. The antisense p21 oligonucleotide inhibited the fimbria-stimulated expression of the p21 protein and also blocked the fimbrial inhibition of cell apoptosis. These observations strongly suggest that fimbrial inhibition of cell apoptosis is mediated by the action of the p21 protein.
Since we showed earlier that fimbrial signaling of P. gingivalis occurred via ␤ 2 integrin on macrophages (40), our interest was in exploring a possible intracellular signaling pathway responsible for the inhibitory effects of the fimbriae on the apoptotic cells. A recent study (36) demonstrated that lipopolysaccharide inhibited growth factor withdrawal-induced apoptosis of dendritic cells via an ERK-and MAPK-dependent pathway. Therefore, we investigated the possibility that the fimbriae inhibited serum withdrawal-induced apoptosis via the ERK-and MAPK-dependent expression of p21. Our Western blot analysis using phosphospecific antibody against ERK and MAPK showed that the fimbriae increased the phosphorylation of ERK and MAPK in the cells at 6 h after the initiation of the treatment and that this increase was sustained up to 24 h. However, the total amount of the ERK and MAPK proteins was not affected by the fimbriae within the period tested. Using PD98059, a MEK1-specific inhibitor, we addressed whether the increased phosphorylation of ERK and MAPK was MEK dependent. The fimbrial inhibition of the apoptotic cells was blocked by the inhibitor. In addition, the fimbrial stimulation of p21 expression in the cells was inhibited by PD98059 treatment. Since PD98059 has little effect on other kinases, including cyclic-AMP-dependent kinase, protein ki- nase C, and other serine and threonine kinases, these results suggest that the fimbrial inhibition of cell apoptosis under growth factor deprivation is mediated by the phosphorylated ERK-and MAPK-dependent expression of p21.
On the other hand, Bcl-2 prevents apoptosis induced by a wide range of agents. Our Western blot analysis showed that there was no change in expression of the Bcl-2 protein following fimbrial treatment. Several studies (33, 45) have demonstrated that protection from apoptosis stimuli is not determined simply by Bcl-2 expression per se but by heterodimers of Bcl-2 and its homologues. Although other members of the Bcl-2 family were not examined here, Bcl-2 protein expression probably does not contribute to the fimbrial inhibition of growth factor withdrawal-induced apoptosis of the cells.
In addition, our interest was to identify the target molecule of the p21 protein that contributes to the fimbrial inhibition of THP-1 cell apoptosis under growth factor deprivation. In order to elucidate this point, it was important for us to address the question of which molecule plays a central role in the induction of cell apoptosis. A recent study (13) demonstrated that caspase-3 plays an important role in spontaneous monocyticcell apoptosis. In this study, we observed that Ac-DEVD-CHO, a potent inhibitor of caspase-3, significantly blocked growth factor withdrawal-induced cell apoptosis. However, such blockage was not observed with Ac-YVAD-CHO, a caspase-1 inhibitor. These observations suggest an important role for caspase-3 in cell apoptosis under growth factor deprivation. Interestingly, recent studies (38, 39) have shown that p21 acts as a caspase-3 inactivator. Therefore, we assumed that caspase-3 might be a target molecule of the p21 protein that contributes to the fimbrial inhibition of THP-1 cell apoptosis. As expected, the fimbriae inhibited caspase-3 activity of the cells induced by the absence of serum. And, interestingly, the fimbrial inhibition of caspase-3 activity was blocked by PD98059 and antisense p21 oligonucleotide treatment. These results strongly suggest that caspase-3 is a target molecule of p21 that mediates the fimbrial inhibition of THP-1 cell apoptosis under growth factor deprivation.
In view of the signaling pathway of the fimbriae described above, although it is of interest to demonstrate whether the fimbria-induced ERK-p21-caspase-3 signaling pathway is mediated via binding of the fimbriae to ␤ 2 integrin, as suggested by our previous study (40) , this point still remains obscure.
An understanding of the processes regulating apoptosis of monocytes/macrophages is critical to the elucidation of the pathogenic mechanism of chronic inflammation. Although the inflammatory reaction in bacterial infection has been well demonstrated, we suggest here that bacterial fimbriae act as inhibitors of growth factor withdrawal-induced apoptosis of cultured monocytic cells through p21 expression via the ERKand MAPK-dependent pathway. This action suggests that bacterial fimbriae play a functional role as potent regulators of chronic inflammatory disease, such as periodontal disease caused by periodontal pathogens.
In conclusion, the present study shows that P. gingivalis fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via ERK-and MAPK-dependent expression of p21. 
